Suchergebnisse - "Davis, John M"

PubPharm (25)

1

Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine : Randomized, Double-Blind Trial in Patients With Schizophrenia

enthalten in: Schizophrenia bulletin | 2022

von Heres, S. | Cordes, J. | Feyerabend, S. | +29

2

Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients : Rationale and trial design

enthalten in: Schizophrenia research | 2021

von Li, X. | Guo, X. | Fan, X. | +20

3

Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysis

enthalten in: Schizophrenia research | 2021

von Paris, G. | Bighelli, I. | Deste, G. | +6

4

Antipsychotic drugs : from 'major tranquilizers' to Neuroscience-based-Nomenclature

enthalten in: Psychological medicine | 2021

von Siafis, S. | Davis, J. | Leucht, S.

CommentOn: Psychol Med. 2020 Nov;50(15):2622-2633. - PMID 31625485

5

Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia : a systematic review and meta-analysis

enthalten in: Psychological medicine | 2020

von Siafis, S. | Deste, G. | Ceraso, A. | +7

CommentIn: Psychol Med. 2021 Feb;51(3):521. - PMID 31806070

6

Risperidone (depot) for schizophrenia

enthalten in: The Cochrane database of systematic reviews | 2016

von Sampson, S. | Hosalli, P. | Furtado, V. | +1

UpdateOf: Cochrane Database Syst Rev. 2003;(4):CD004161. - PMID 14584007

7

Initial severity of schizophrenia and efficacy of antipsychotics : participant-level meta-analysis of 6 placebo-controlled studies

enthalten in: JAMA psychiatry | 2015

von Furukawa, T. | Levine, S. | Tanaka, S. | +5

8

Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients

enthalten in: Psychiatry research | 2012

von Smith, R. | Rachakonda, S. | Dwivedi, S. | +1

9

Absence of tolerance to the anticonvulsant and neuroprotective effects of imidazenil against DFP-induced seizure and neuronal damage

enthalten in: Neuropharmacology | 2011

von Kadriu, B. | Gocel, J. | Larson, J. | +4

10

Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia : a data-driven, personalized clinical approach

enthalten in: The Journal of clinical psychiatry | 2011

von Glick, I. | Correll, C. | Altamura, A. | +5